Guideline / position statementindependent cross-checkabstract checked★ key study I-CAN-105 in-depth review

US cancer doctors' guideline: exercise helps, diet evidence weak

Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline.

Overview

Ligibel JA et al.. J Clin Oncol 2022 · PMID 35576506 · DOI 10.1200/JCO.22.00687

ASCO found that exercise helps during cancer treatment but that evidence for specific diets is very limited.

Does the study support the specific claim? No · Methodological quality: high

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Guide exercise, diet and weight during cancer treatment.

How was the study done?

Systematic review plus expert panel.

How many people, animals or samples were studied?

52 reviews and 23 RCTs.

What was actually found?

Exercise helps; no diet shown to control cancer.

How large was the observed effect?

Not applicable.

What do the results mean in everyday life?

Diet can support, not replace, treatment.

What are the study's limitations?

Few diet trials.

What does it say about Elawady's specific claim?

Contradicts diet as cancer cure.

Do the results apply to Germany and Europe?

High.

What can explicitly not be concluded from this study?

Absence of effect for all diets.

Scientific in-depth review

1. Full reference

Authors
Ligibel JA et al.
Journal
J Clin Oncol
Year
2022
Identifier
PMID 35576506 DOI 10.1200/JCO.22.00687
Verification
verified – PubMed efetch 2026-10-26 + Crossref
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

ASCO guideline; COI disclosures in full text (not read)

2. Research question

Exercise, diet and weight management during active cancer treatment in adults

3. Study design and population

Study design
Guideline / position statement – Clinical practice guideline based on a systematic review (52 systematic reviews, 23 RCTs)
Population

Adults receiving cancer treatment

Country

USA (ASCO), international evidence

Period

Literature January 2000 - May 2021

Sample size

52 systematic reviews (9 on diet) and 23 RCTs

Inclusion and exclusion criteria

Systematic reviews and RCTs during treatment

4. Methods and endpoints

Exposure / intervention

Exercise, specific diets and foods, intentional weight loss

Comparator

Usual care

Endpoints

Quality of life, treatment toxicity, cancer control

Statistical methods

Expert panel synthesis

5. Actual results

Results

Exercise improved fitness, strength and fatigue. Neutropenic diets did not reduce infection. 'Evidence for other dietary and weight loss interventions during cancer treatment was very limited.'

Absolute risks

not applicable

Authors' conclusion

Recommend exercise during curative treatment; neutropenic diets not recommended; evidence for other diets very limited.

6. Strengths

  • Systematic evidence base
  • Major oncology society

7. Weaknesses

  • Evidence base for diet thin
  • Abstract only

8. Risk of bias

Orienting tool
none applicable
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
not assessable
Rationale

Guideline.

9. Assessment of the statistical interpretation

Not applicable.

10. Relevance to the specific claim

Major oncology guideline: no specific diet has evidence for cancer control during treatment.

11. Independent contrary findings

12. Transferability to Germany and Europe

High (consistent with ESPEN/ESMO).

13. Overall methodological judgement

Authoritative statement that diet-as-treatment lacks evidence.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualityhigh
Risk of biaslow
Precision of resultsnot applicable
Directnessdirect
Reproducibilitynot replicated
Consistency with the overall evidenceconsistent
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Diet trials with cancer-control outcomes.

15. Linked fact checks